APYX MEDICAL CORP APYX Cash Flow

Apyx medical corp (APYX)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Net loss
-1,951	-	-4,881	-3,411	-5,608	-	68,469	-272	-935	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash flows from operating activities
Net income (loss)
-	-	-	-	-	-	-	-	-	-	-	-1,308	-1,685	-	-965	-519	-1,944	-1,407	-1,588	-1,499	-876	-5,190	-2,736	251	-9,607	-2,469	-341	-1,120	-409	286	-8	152	187	-	63	429	492
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
214	244	194	122	194	240	58	172	199	169	171	178	178	178	201	173	182	181	210	204	217	220	203	221	232	207	204	204	212	102	200	216	224	76	224	224	229
Provision for inventory obsolescence
10	17	79	-5	41	-	-	47	-47	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of intangible assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Provision for inventory obsolescence
-	-	-	-	-	-	-	-	-	-	-	107	-24	-	31	-75	409	199	96	-61	-77	-252	90	842	53	-28	43	-1	-2	-74	25	-16	-28	3	-25	1	58
Gain on disposal of property and equipment, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-2	-5	-8	-6	-3	-18	0	0	-25	9	-2	4	-13	-3	1	-1	-	-	-	-	-	-	-	-
Loss on disposal of property and equipment, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-5	0	-	-	-	-
Stock based compensation
1,049	987	879	520	1,195	986	489	377	372	339	191	182	159	276	173	184	176	195	138	124	118	110	127	69	82	158	54	244	50	52	45	32	32	27	38	26	41
Change in fair value of derivative liabilities
-	-	-	-	-	0	0	-46	26	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Unrealized gain on short term investments
0	-	-	-	164	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Unrealized gain on short term investments
-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of derivative liabilities
-	-	-	-	-	-	-	-	-	-	-	38	88	-	-683	41	87	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Provision (benefit) for allowance for doubtful accounts
324	-69	63	81	-238	101	41	91	-9	51	-31	166	-7	-42	-33	53	106	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Benefit of deferred taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-14	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non cash other (income) loss - warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	266	90	1,444	-	1,675	-1,454	9,599	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	13	38	-34	-	-135	44	-17	-	-67	107	141
Benefit (provision) for deferred taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-1,350	-584	34	-538	-172	-554	-349	-88	95	73	130	-	-	-	182
Changes in operating assets and liabilities:
Trade receivables
-1,520	1,390	1,534	961	85	1,042	-1,412	540	277	831	-883	816	-461	824	330	418	322	497	483	643	-594	-34	571	-382	-245	-106	-278	448	-948	236	14	59	349	56	-37	-347	454
Prepaid expenses and other assets
6,024	-190	-245	492	349	-	-	-	-	-191	96	-101	226	-151	28	2	18	-309	-136	-48	207	317	254	125	-437	-129	-267	-177	167	-83	-22	-65	411	-	-	-	-91
Prepaid expenses
-	-	-	-	-	-	-	-	26	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Inventories
855	-96	1,247	1,046	170	-2,891	699	871	136	-809	-330	267	1,240	-136	-455	-221	1,013	-259	-125	159	327	-2,902	349	503	95	-138	323	148	551	127	453	-702	-165	632	418	-187	-144
Deposits and other assets
-	-	-	-	-	-	-	-	-4	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deposits and other assets
-	-	-	-	-	-	-	-	-	-	-	-70	-2	29	268	5	39	194	162	-29	-99	223	899	33	-203	129	14	-123	-254	-	-	-	-	-	-	-	-
Deposits
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-165	-128	4	-	-	-	-35
Accounts payable
107	1,004	-168	137	81	-989	-397	648	514	196	-690	-99	570	-44	-124	232	328	-977	598	-133	323	183	340	0	-29	-111	343	-57	82	184	-25	-79	-364	374	-233	171	-178
Accrued severance and related
-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Litigation settlement liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-441	-	-	-	0	-	-	-	-	-	-	-	-
Accrued and other liabilities
-1,801	814	952	590	14	-13,504	-939	-105	-793	960	-122	786	-914	1,100	-274	52	-115	448	210	-92	-13	701	267	-327	-186	12	-273	849	154	-220	-111	21	-93	-235	6	-109	308
Accrued payroll
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-
Accrued vacation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-
Net cash used in operating activities
-7,407	-3,381	-4,953	-5,052	-5,089	-18,046	-1,154	-573	-1,108	731	-541	-1,076	-2,818	-544	87	-113	-2,267	-1,021	-644	-2,330	-1,791	198	698	-264	-1,049	-1,347	78	-1,014	-253	11	-300	940	-486	-248	-72	1,480	737
Cash flows from investing activities
Purchases of property and equipment
90	225	154	805	117	160	-129	193	139	193	280	80	71	104	141	20	21	-183	142	208	254	311	155	89	75	171	124	162	131	304	162	44	243	83	198	186	75
Purchases of marketable securities
0	0	0	0	18,884	31,756	55,433	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from maturities of marketable securities
0	0	0	40,884	39,842	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash (used in) provided by investing activities
-90	-225	-154	40,079	20,841	-6,158	35,791	-193	-139	-193	-280	-80	-71	-104	-141	-20	-21	-317	-142	-208	-254	-311	-155	-89	-75	-171	-124	-162	-131	-304	-162	-44	-243	-83	-198	-186	-75
Cash flows from financing activities
Proceeds from stock option exercises
72	53	39	48	67	137	65	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repayment of finance lease liabilities
57	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from stock options/warrants exercised
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-39	1,289	177	-	78	171	0	7,000	24	6	18	0	0	0	0	-	-	-	-
Change in restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-60	0	0	0	0	-60	1	0	898	0	-	-	-	-	-	-	-	-	-	-	-	-
Repayment of mortgage note payable
-	-	-	-	-	-	-	-	-60	-	-60	-60	-59	-60	-60	-59	-61	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repayment of mortgage note payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	60	60	60	-	60	60	-3,592	-103	103	0	0	-97	33	32	32	3,635	36	34	35
Proceeds from issuance of common shares, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	11,531	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Repayment of industrial revenue bonds
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	3,257	162	-68	34	34	-	-	-	-	-	-	-	-
Repurchase of warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1	1	-1	421	0	0	0	0	-	-	-	-	-	-	-	-
Net cash provided by financing activities
15	-5	37	48	67	137	-2,509	-60	-60	-60	-60	-60	-59	5,715	59	1	-61	-59	-99	1,229	11,708	-289	17	-786	-86	6,941	-11	-28	-16	-33	-33	-32	-32	-197	-36	-34	-35
Effect of exchange rates on cash
50	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net change in cash, cash equivalents and restricted cash
-7,432	-3,590	-5,088	35,075	15,819	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net change in cash, cash equivalents and restricted cash
-	-	-	-	-	-	-	-	-1,307	-	-881	-1,216	-2,948	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net change in cash and cash equivalents
-	-	-	-	-	-	-	-	-	-	-	-	-	-	5	-132	-2,349	-1,397	-885	-1,309	9,663	-402	560	-1,139	-1,210	5,423	-57	-1,204	-400	-326	-495	864	-761	-528	-306	1,260	627
Cash paid for:
Interest
6	8	0	0	0	-	-	38	34	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest paid
-	-	-	-	-	-	-	-	-	-	-	36	31	-	75	12	38	38	40	40	40	40	42	41	28	24	55	61	55	57	59	58	58	-378	43	150	-52
Non cash financing activities:
Cashless exercise of stock options/warrants
11	-345	295	-48	710	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Lease adoption
0	-	-	-	212	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Capitalization of Lease
-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-